{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:59:09Z","timestamp":1789595949117,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018493","name":"Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["110TMUSHH-008"],"award-info":[{"award-number":["110TMUSHH-008"]}],"id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["TMU-JIRB N202205004"],"award-info":[{"award-number":["TMU-JIRB N202205004"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.eprac.2023.01.007","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T19:38:11Z","timestamp":1673897891000},"page":"247-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metformin Adherence Reduces the Risk of Dementia in Patients With Diabetes: A Population-based Cohort Study"],"prefix":"10.1016","volume":"29","author":[{"given":"Po-Chih","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Tai","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lung","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Nien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2023.01.007_bib1","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","article-title":"Metformin: historical overvie","volume":"60","author":"Bailey","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.eprac.2023.01.007_bib2","series-title":"Type 2 diabetes in adults: Management","year":"2022"},{"key":"10.1016\/j.eprac.2023.01.007_bib3","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.2337\/dc19-S009","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical Care in diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2023.01.007_bib4","first-page":"354","article-title":"Driessen JH,et al. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study","volume":"13","author":"van Dalem","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.eprac.2023.01.007_bib5","article-title":"Metformin use was associated with reduced risk of incidental sjogren's syndrome in patients with type 2 diabetes: a population-based cohort study","volume":"12","author":"Wang","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.eprac.2023.01.007_bib6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.numecd.2017.04.009","article-title":"Natali A Metformin effects on the heart and the cardiovascular system: a review of experimental and clinical data","volume":"27","author":"Nesti","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.eprac.2023.01.007_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-3-030-42667-5_13","article-title":"The use of metformin to increase the human healthspan","volume":"1260","author":"Piskovatska","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.eprac.2023.01.007_bib8","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diabres.2018.05.023","article-title":"Metformin in cancer","volume":"143","author":"Mallik","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.eprac.2023.01.007_bib9","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.eprac.2023.01.007_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001370","article-title":"Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis","volume":"8","author":"Ping","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.eprac.2023.01.007_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-131901","article-title":"Long-term metformin usage and cognitive function among older adults with diabetes","volume":"41","author":"Ng","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.eprac.2023.01.007_bib12","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1007\/s11095-017-2199-y","article-title":"Metformin - a future therapy for neurodegenerative diseases: theme: drug discovery, development and delivery in alzheimer's disease guest editor: davide brambilla","volume":"34","author":"Markowicz-Piasecka","year":"2017","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.eprac.2023.01.007_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s12877-017-0574-5","article-title":"Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing","volume":"17","author":"Schlender","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.eprac.2023.01.007_bib14","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.2174\/1381612827666210728102832","article-title":"Polypharmacy in chronic neurological diseases: multiple sclerosis, dementia and Parkinson's disease","volume":"27","author":"Frahm","year":"2021","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.eprac.2023.01.007_bib15","article-title":"Neurological complications in chronic kidney disease","volume":"5","author":"Arnold","year":"2016","journal-title":"JRSM Cardiovasc Dis"},{"key":"10.1016\/j.eprac.2023.01.007_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.14336\/AD.2017.1202","article-title":"Metformin and the risk of dementia in type 2 diabetes patients","volume":"10","author":"Chin-Hsiao","year":"2019","journal-title":"Aging Dis"},{"key":"10.1016\/j.eprac.2023.01.007_bib17","series-title":"Random assignment of proxy event dates to unexposed individuals in observational studies: An automated technique using SAS \u00ae . Business","author":"Harvey","year":"2012"},{"key":"10.1016\/j.eprac.2023.01.007_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000107084","article-title":"Validity of dementia diagnoses in the Danish hospital registers","volume":"24","author":"Phung","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.eprac.2023.01.007_bib19","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.parkreldis.2014.09.026","article-title":"Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study","volume":"20","author":"Lin","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.eprac.2023.01.007_bib20","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.2337\/dc13-0229","article-title":"AIBL Investigators Increased risk of cognitive impairment in patients with diabetes is associated with metformin","volume":"36","author":"Moore","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2023.01.007_bib21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/gps.4900","article-title":"Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: results from the population-based Mayo Clinic Study of Aging","volume":"33","author":"Wennberg","year":"2018","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.eprac.2023.01.007_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7208429","article-title":"The effect of diabetes medication on cognitive function: evidence from the PATH through life study","volume":"2016","author":"Herath","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.eprac.2023.01.007_bib23","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s43440-020-00095-1","article-title":"Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation","volume":"72","author":"Ozbey","year":"2020","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.eprac.2023.01.007_bib24","doi-asserted-by":"crossref","first-page":"108173","DOI":"10.1016\/j.neuropharm.2020.108173","article-title":"Metformin regulates astrocyte reactivity in Parkinson\u2019s disease and normal aging","volume":"175","author":"Ryu","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eprac.2023.01.007_bib25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/15376516.2020.1741053","article-title":"Protective effect of metformin against rotenone-induced parkinsonism in mice","volume":"30","author":"Wang","year":"2020","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.eprac.2023.01.007_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024954","article-title":"Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus","volume":"9","author":"Shi","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.eprac.2023.01.007_bib27","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jdiacomp.2017.09.001","article-title":"Brain gray matter changes in type 2 diabetes mellitus: a meta-analysis of whole-brain voxel-based morphometry study","volume":"31","author":"Wu","year":"2017","journal-title":"J\u00a0Diabetes Complicat"},{"key":"10.1016\/j.eprac.2023.01.007_bib28","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11682-014-9348-2","article-title":"Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes","volume":"9","author":"Moulton","year":"2015","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/j.eprac.2023.01.007_bib29","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease- associated A\u03b2 oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eprac.2023.01.007_bib30","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1056\/NEJM199810153391607","article-title":"Parkinson's disease. Second of two parts","volume":"339","author":"Lang","year":"1998","journal-title":"N\u00a0Engl J Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23000204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X23000204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:14:55Z","timestamp":1761516895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X23000204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1530891X23000204"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2023.01.007","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin Adherence Reduces the Risk of Dementia in Patients With Diabetes: A Population-based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2023.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the AACE.","name":"copyright","label":"Copyright"}]}}